115 related articles for article (PubMed ID: 12370738)
21. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
Recio JA; Merlino G
Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
[TBL] [Abstract][Full Text] [Related]
23. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
24. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
[TBL] [Abstract][Full Text] [Related]
25. CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.
Peng ST; Su CH; Kuo CC; Shaw CF; Wang HS
Int J Oncol; 2007 Nov; 31(5):1119-26. PubMed ID: 17912438
[TBL] [Abstract][Full Text] [Related]
26. HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells.
Ye L; Lewis-Russell JM; Sanders AJ; Kynaston H; Jiang WG
Urol Oncol; 2008; 26(2):190-7. PubMed ID: 18312940
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of ezrin/radixin/moesin (ERM) and ERM-associated adhesion molecules in the blastocyst and uterus suggests their functions during implantation.
Matsumoto H; Daikoku T; Wang H; Sato E; Dey SK
Biol Reprod; 2004 Mar; 70(3):729-36. PubMed ID: 14613898
[TBL] [Abstract][Full Text] [Related]
28. CD-44 is not involved in the metastatic spread of ovarian cancer in vivo.
Speiser P; Wanner C; Breitenecker G; Kohlberger P; Kainz C
Anticancer Res; 1995; 15(6B):2767-9. PubMed ID: 8669861
[TBL] [Abstract][Full Text] [Related]
29. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
30. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).
Hall CL; Tsan R; Mugnai G; Mazar A; Radinsky R; Pettaway CA
Prostate; 2004 May; 59(2):167-76. PubMed ID: 15042617
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
[TBL] [Abstract][Full Text] [Related]
32. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
[TBL] [Abstract][Full Text] [Related]
33. CD44 family and gynaecological cancer.
Makrydimas G; Zagorianakou N; Zagorianakou P; Agnantis NJ
In Vivo; 2003; 17(6):633-40. PubMed ID: 14758731
[TBL] [Abstract][Full Text] [Related]
34. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA
Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337
[TBL] [Abstract][Full Text] [Related]
35. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
[TBL] [Abstract][Full Text] [Related]
36. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate.
Gao AC; Lou W; Sleeman JP; Isaacs JT
Cancer Res; 1998 Jun; 58(11):2350-2. PubMed ID: 9622073
[TBL] [Abstract][Full Text] [Related]
37. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
Keledjian K; Kyprianou N
J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
[TBL] [Abstract][Full Text] [Related]
38. Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells.
Furbert-Harris PM; Parish-Gause D; Hunter KA; Vaughn TR; Howland C; Okomo-Awich J; Forrest K; Laniyan I; Abdelnaby A; Oredipe OA
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1009-16. PubMed ID: 14682382
[TBL] [Abstract][Full Text] [Related]
39. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.
Patrawala L; Calhoun T; Schneider-Broussard R; Li H; Bhatia B; Tang S; Reilly JG; Chandra D; Zhou J; Claypool K; Coghlan L; Tang DG
Oncogene; 2006 Mar; 25(12):1696-708. PubMed ID: 16449977
[TBL] [Abstract][Full Text] [Related]
40. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]